Tersis Technologies Appoints Veteran Patent Strategist Kevin H. Fortin as Vice President of Intellectual Property & Licensing
Brooksville, Florida--(Newsfile Corp. - March 18, 2026) - Tersis Technologies, Inc. (OTCID: TERS) today announced the appointment of Kevin H. Fortin, Esq. as Vice President of Intellectual Property & Licensing, a strategic leadership addition intended to accelerate the Company's patent protection initiatives, strengthen technology defensibility, and develop high-margin intellectual property licensing revenue streams. Mr. Fortin is a registered U.S. Patent Attorney with more than 30
Agriculture, Energy, Alternative Energy, Health
2026-03-18 12:53 PM EDT | Tersis Technologies Inc.
Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate
Ontario and Arlington, Massachusetts--(Newsfile Corp. - March 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Kala Bio, Inc. (NASDAQ: KALA) ("Kala Bio") today announced that Red Li
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-03-18 8:15 AM EDT | Red Light Holland Corp.
ALST Announces Formal Offer to Acquire 55% Stake in Imperia Calcio
Sunny Isles Beach, Florida--(Newsfile Corp. - March 17, 2026) - ALST (OTCID: ALST) is pleased to formally announce that a strategic offer has been placed to acquire a 55% ownership stake in Imperia Calcio, in collaboration with a team of distinguished investors. This proposal represents a significant step in ALST's continuing commitment to fostering growth in the sports industry and supporting the future development of Imperia Calcio, a club with a rich history and passionate fanbase. T
Healthcare and Hospitals, Retail, Health
2026-03-17 11:31 AM EDT | Allstar Health Brands, Inc.
Adia Med of Winter Park Appoints Amy Dalrymple, APRN, Former Mrs. Florida United States, to Lead Regenerative Aesthetics Division
Winter Park, Florida--(Newsfile Corp. - March 17, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) is proud to announce that its subsidiary, Adia Med of Winter Park, has appointed Amy Dalrymple, MSN, APRN, FNP-C, a highly experienced aesthetic nurse practitioner and former Mrs. Florida United States, as the leader of its new Regenerative Aesthetics Division.
Healthcare and Hospitals, Health
2026-03-17 9:30 AM EDT | Adia Nutrition Inc.
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 17, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its proprietary Botanical Synthesis™ platform, today announced that it will report its fourth quarter and full year 2025 financial results after market close on Tuesday, March 31, 2026. The Company will host a conference call and webcast at 4:30 p.m. Eastern Daylight Time to discuss the re
Biotechnology, Pharmaceuticals, Health
2026-03-17 8:30 AM EDT | BioHarvest Sciences Inc.
Rise Nano Optics Appoints Erik Ritchie as Chief Commercial Officer to Lead North American Commercialization Strategy
Vancouver, British Columbia--(Newsfile Corp. - March 17, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company"), a health technology company advancing vision care through patented nanotechnology lens solutions, today announced the appointment of Erik Ritchie as Chief Commercial Officer (CCO). Mr. Ritchie will lead Rise's North American commercialization strategy, overseeing go-to-market execution, operations, partnerships, and sales and
2026-03-17 7:00 AM EDT | Rise Nano Optics Ltd.
UBERDOC Health Technologies Corp. Announces Completion of Amalgamation with ROV Investment Partners Corp. and Listing on the CSE
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - UBERDOC Health Technologies Corp. (CSE: SEEM) (OTCQB: ESVNF) ("UBERDOC" or the "Company") is pleased to announce that it has completed its previously announced amalgamation effective March 13, 2026 pursuant to an amalgamation agreement dated May 1, 2025 as amended from time to time (the "Amalgamation Agreement") with ROV Investment Partners Corp. ("ROV") and 1536702 B.C. Ltd. ("Subco
2026-03-16 2:29 PM EDT | UBERDOC Health Technologies Corp.
Phio Pharmaceuticals Announces "A Groundbreaking Approach to Treating Skin Cancer" in a Fireside Chat with Force Family Office
King of Prussia, Pennsylvania--(Newsfile Corp. - March 16, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silenc
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-03-16 11:30 AM EDT | Phio Pharmaceuticals Corp.
Functional Brands Inc. to Participate in the 38th Annual ROTH Conference
Lake Oswego, Oregon--(Newsfile Corp. - March 16, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that it will participate in the 38th Annual ROTH Conference, taking place March 22-24, 2026, in Dana Point, California. Eric Gripentrog, Chief Executive Officer & Director, and David R. Wells, Financial Counsel, will participate in the event and meet with investors. The conference will feature a combination of one-o
Household / Consumer / Cosmetics, Health
2026-03-16 8:00 AM EDT | Functional Brands Inc.
Optimi Health Announces Proposed Nasdaq Listing and U.S. Underwritten Public Offering
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2026) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (the "Company" or "Optimi"), a commercial-stage pharmaceutical company focused on manufacturing and distributing finished psychedelic drug products, today announced that it has commenced an underwritten public offering in the United States (the "Offering") of its common shares, no par value (the "Shares"), pursuant to a registration statement filed wi
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-03-16 7:00 AM EDT | Optimi Health Corp.
Promino Nutritional Sciences Inc. Initiates Largest Production Run in Company History - Approximately 3.5 Million Servings of Rejuvenate Muscle Health(R)
Largest Production Order to Date: Approximately 3.5 million stick production run (≈225,000 units) initiated to support increasing retail and e-commerce demand, with product expected to reach market starting in April. Proprietary Formula with Planned Patent Filing: First large-scale run utilizing the Company's new proprietary formulation; patent filing expected in Q2 2026. Rejuvenate Channel Expansion: In addition t
Food / Beverages, Sports, Health
2026-03-16 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Cosmo Highlights Leadership in Real Time Medical AI at NVIDIA GTC 2026
Dublin, Ireland--(Newsfile Corp. - March 16, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced its participation at NVIDIA GTC 2026, the world’s leading conference for artificial intelligence (AI) and accelerated computing, taking place in San Jose (CA), USA, from March 16 to March 19. At the conference, Cosmo will present a technical session titled “Engineering Medical Grade Platforms for Real Time AI
Healthcare and Hospitals, Health
2026-03-16 2:09 AM EDT | Cosmo Pharmaceuticals N.V.
Therma Bright Grants Stock Options
Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces that it has granted incentive stock options to its directors, officers and certain consultants of the Company to purchase up to an aggregate of 2,850,000 common shares of the Company pursuant to its 10% rolling stock option plan. All option
Technology, Biotechnology, Health
2026-03-13 5:54 PM EDT | Therma Bright Inc.
Promino Announces Proposed Private Placement
Burlington, Ontario--(Newsfile Corp. - March 13, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company") announces that it intends to complete a non-brokered private placement for aggregate gross proceeds of up to $1,200,000 through the issuance of up to 40,000,000 units of the Company ("Units") at a price of $0.03 per Unit (the "Offering"). Each Unit will consist of one common share (each, a "Share") and one half of one common share purchase
Food / Beverages, Sports, Health
2026-03-13 5:30 PM EDT | Promino Nutritional Sciences, Inc.
Numinus Wellness Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 13, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update. Corporate Update Over the past year, Numinus has undertaken a strategic transformation to streamline its operations and focus on its core
2026-03-13 5:00 PM EDT | Numinus Wellness Inc.
BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors
British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that its Board of Directors has approved the grant of long-term incentive ("LTI") awards to employees, officers and directors under the Company's equity incentive plan. These
Biotechnology, Pharmaceuticals, Health
2026-03-13 4:53 PM EDT | BioHarvest Sciences Inc.
Safe Supply Streaming Co Ltd. Announces Annual General and Special Meeting of Shareholders to Be Held on April 8, 2026
Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or the "Company") announces that it will hold its Annual General and Special Meeting of Shareholders (the "Meeting") on Wednesday, April 8, 2026, at 11:00 a.m. (Toronto time) at the offices of Garfinkle Biderman LLP, 1 Adelaide Street East, 8th Floor, Suite 801, Toronto, Ontario M5C 2V9. The Meeting has been called to addres
2026-03-13 7:06 AM EDT | Safe Supply Streaming Co Ltd.
Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026
Singapore, Singapore--(Newsfile Corp. - March 12, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI HealthTech platform, today announced that, for the first six months of fiscal 2026 ended December 31, 2025, the Company achieved significant improvements in its gross margin and cash position while slashing its total operating expenses and net loss. Gross margin for the first half of fiscal 2026 was 20.1 percent, compared with 14.
2026-03-12 8:30 AM EDT | Mobile-health Network Solutions
Aleen Inc. Advances Work Toward Web Integration of Personal Account
Toronto, Ontario--(Newsfile Corp. - March 12, 2026) - Aleen Inc. (CSE: ALEN.U), a digital wellness company, announces ongoing work to bring its Personal Wellness Account environment to the web, building on prior advancements in Wellness AI Agents and Personal Wellness Account development. Current efforts are focused on exploring options and identifying optimal solutions for a first test version, moving steadily toward a point where users will soon be able to access and experience
2026-03-12 8:17 AM EDT | Aleen Inc.
Rise Nano Optics to Commence Trading on the Canadian Securities Exchange Under the Symbol "EYE", Today, March 12, 2026
Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Rise Nano Optics Ltd. (CSE: EYE) ("Rise" or the "Company") is pleased to announce that it has received approval to list its common shares (the "Common Shares") on the Canadian Securities Exchange (the "CSE"). Trading is expected to commence on the CSE under the symbol "EYE" at the open of markets on March 12, 2026. Inas Said, CEO of Rise commented, "Listing publicly r
2026-03-12 7:00 AM EDT | Rise Nano Optics Ltd.